BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 8519652)

  • 1. Carboplatin- and cisplatin-induced potentiation of moderate-dose radiation cytotoxicity in human lung cancer cell lines.
    Groen HJ; Sleijfer S; Meijer C; Kampinga HH; Konings AW; De Vries EG; Mulder NH
    Br J Cancer; 1995 Dec; 72(6):1406-11. PubMed ID: 8519652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of cellular glutathione to the cytotoxicity and resistance of seven platinum compounds.
    Meijer C; Mulder NH; Timmer-Bosscha H; Sluiter WJ; Meersma GJ; de Vries EG
    Cancer Res; 1992 Dec; 52(24):6885-9. PubMed ID: 1458477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of apoptosis-related proteins and morphological changes in a rat tumor model of human small cell lung cancer prior to and after treatment with radiotherapy, carboplatin, or combined treatment.
    Fokkema E; De Vries EG; Groen HJ; Meijer C; Timens W
    Virchows Arch; 2003 Apr; 442(4):349-55. PubMed ID: 12715170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The formation and removal of cisplatin (CDDP) induced DNA adducts in a CDDP sensitive and resistant human small cell lung carcinoma (HSCLC) cell line.
    Hospers GA; de Vries EG; Mulder NH
    Br J Cancer; 1990 Jan; 61(1):79-82. PubMed ID: 2153398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of human small-cell lung carcinoma (hSCLC) cell lines with different sensitivities to detect relevant mechanisms of cisplatin (CDDP) resistance.
    Hospers GA; Meijer C; de Leij L; Uges DR; Mulder NH; de Vries EG
    Int J Cancer; 1990 Jul; 46(1):138-44. PubMed ID: 2163989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line.
    Meijer C; Mulder NH; Hospers GA; Uges DR; de Vries EG
    Br J Cancer; 1990 Jul; 62(1):72-7. PubMed ID: 2390486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiopotentiation by the oral platinum agent, JM216: role of repair inhibition.
    Amorino GP; Freeman ML; Carbone DP; Lebwohl DE; Choy H
    Int J Radiat Oncol Biol Phys; 1999 May; 44(2):399-405. PubMed ID: 10760436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a human small cell lung carcinoma cell line with acquired resistance to cis-diamminedichloroplatinum(II) in vitro.
    Hospers GA; Mulder NH; de Jong B; de Ley L; Uges DR; Fichtinger-Schepman AM; Scheper RJ; de Vries EG
    Cancer Res; 1988 Dec; 48(23):6803-7. PubMed ID: 2846161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation sensitivities in various anticancer-drug-resistant human lung cancer cell lines and mechanism of radiation cross-resistance in a cisplatin-resistant cell line.
    Oshita F; Fujiwara Y; Saijo N
    J Cancer Res Clin Oncol; 1992; 119(1):28-34. PubMed ID: 1400562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of platinum drugs with clinically relevant x-ray doses in mammalian cells: a comparison of cisplatin, carboplatin, iproplatin, and tetraplatin.
    Skov K; MacPhail S
    Int J Radiat Oncol Biol Phys; 1991 Feb; 20(2):221-5. PubMed ID: 1991682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperthermic potentiation of cisplatin toxicity in a human small cell lung carcinoma cell line and a cisplatin resistant subline.
    Hettinga JV; Lemstra W; Meijer C; Mulder NH; Konings AW; de Vries EG; Kampinga HH
    Int J Hyperthermia; 1994; 10(6):795-805. PubMed ID: 7884239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of novobiocin on cisplatin cytotoxicity and DNA interstrand cross-link formation in a cisplatin-resistant, small-cell lung carcinoma cell line.
    de Jong S; Timmer-Bosscha H; de Vries EG; Mulder NH
    Int J Cancer; 1993 Jan; 53(1):110-7. PubMed ID: 8380054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of amiodarone, cyclosporin A, and PSC 833 on the cytotoxicity of mitoxantrone, doxorubicin, and vincristine in non-P-glycoprotein human small cell lung cancer cell lines.
    van der Graaf WT; de Vries EG; Timmer-Bosscha H; Meersma GJ; Mesander G; Vellenga E; Mulder NH
    Cancer Res; 1994 Oct; 54(20):5368-73. PubMed ID: 7923167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JM216-, JM118-, and cisplatin-induced cytotoxicity in relation to platinum-DNA adduct formation, glutathione levels and p53 status in human tumour cell lines with different sensitivities to cisplatin.
    Fokkema E; Groen HJ; Helder MN; de Vries EG; Meijer C
    Biochem Pharmacol; 2002 Jun; 63(11):1989-96. PubMed ID: 12093475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interactions of carboplatin, cisplatin, and ionizing radiation on a human cell line of ovarian cancer].
    Scalliet P; De Pooter C; Hellemans PW; De Bruijn EA; Van Oosterom AT
    Cancer Radiother; 1999; 3(1):30-8. PubMed ID: 10083861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of ultrafilterable platinum concentration on cisplatin and carboplatin cytotoxicity in human tumor and bone marrow cells in vitro.
    Guchelaar HJ; de Vries EG; Meijer C; Esselink MT; Vellenga E; Uges DR; Mulder NH
    Pharm Res; 1994 Sep; 11(9):1265-9. PubMed ID: 7816754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective potentiation of platinum drug cytotoxicity in cisplatin-sensitive and -resistant human ovarian carcinoma cell lines by amphotericin B.
    Sharp SY; Mistry P; Valenti MR; Bryant AP; Kelland LR
    Cancer Chemother Pharmacol; 1994; 35(2):137-43. PubMed ID: 7987990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cytotoxic activity of cisplatin, carboplatin and teniposide alone and combined determined on four human small cell lung cancer cell lines by the clonogenic assay.
    Roed H; Vindeløv LL; Christensen IJ; Spang-Thomsen M; Hansen HH
    Eur J Cancer Clin Oncol; 1988 Feb; 24(2):247-53. PubMed ID: 2833402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inhibitory effect of cisplatin in combination with irradiation on lung tumor cell growth is due to induction of tumor cell apoptosis.
    Fujita M; Fujita T; Kodama T; Tsuchida T; Higashino K
    Int J Oncol; 2000 Aug; 17(2):393-7. PubMed ID: 10891552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifactorial drug resistance in an adriamycin-resistant human small cell lung carcinoma cell line.
    Zijlstra JG; de Vries EG; Mulder NH
    Cancer Res; 1987 Apr; 47(7):1780-4. PubMed ID: 3028613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.